| 1 |
Syed FZ. Type 1 diabetes mellitus[J]. Ann Intern Med, 2022，175(3)：ITC33-ITC48.
|
| 2 |
Wang Q, Huang YX, Liu L, et al. Pancreatic islet transplantation: current advances and challenges[J]. Front Immunol, 2024，15：1391504.
|
| 3 |
Langlois A, Pinget M, Kessler L, et al. Islet transplantation: current limitations and challenges for successful outcomes[J]. Cells, 2024，13(21)：1783.
|
| 4 |
Ito T, Kenmochi T, Kurihara K, et al. The effects of using pancreases obtained from brain-dead donors for clinical islet transplantation in Japan[J]. J Clin Med, 2019，8(9)：1430.
|
| 5 |
Doppenberg JB, Nijhoff MF, Engelse MA, et al. Clinical use of donation after circulatory death pancreas for islet transplantation[J]. Am J Transplant, 2021，21(9)：3077-3087.
|
| 6 |
Zhao M, Muiesan P, Amiel SA, et al. Human islets derived from donors after cardiac death are fully biofunctional[J]. Am J Transplant, 2007，7(10)：2318-2325.
|
| 7 |
Kaddis JS, Danobeitia JS, Niland JC, et al. Multicenter analysis of novel and established variables associated with successful human islet isolation outcomes[J]. Am J Transplant, 2010，10(3)：646-656.
|
| 8 |
Markmann JF, Deng S, Desai NM, et al. The use of non-heart-beating donors for isolated pancreatic islet transplantation[J]. Transplantation, 2003，75(9)：1423-1429.
|
| 9 |
Andres A, Kin T, O′Gorman D, et al. Clinical islet isolation and transplantation outcomes with deceased cardiac death donors are similar to neurological determination of death donors[J]. Transpl Int, 2016，29(1)：34-40.
|
| 10 |
Hilling DE, Bouwman E, Terpstra OT, et al. Effects of donor-，pancreas-，and isolation-related variables on human islet isolation outcome: a systematic review[J]. Cell Transplant, 2014，23(8)：921-928.
|
| 11 |
Saito T, Gotoh M, Satomi S, et al. Islet transplantation using donors after cardiac death: report of the Japan Islet Transplantation Registry[J]. Transplantation, 2010，90(7)：740-747.
|
| 12 |
Anazawa T, Saito T, Goto M, et al. Long-term outcomes of clinical transplantation of pancreatic islets with uncontrolled donors after cardiac death: a multicenter experience in Japan[J]. Transplant Proc, 2014，46(6)：1980-1984.
|
| 13 |
Berney T, Boffa C, Augustine T, et al. Utilization of organs from donors after circulatory death for vascularized pancreas and islet of Langerhans transplantation: recommendations from an expert group[J]. Transpl Int, 2016，29(7)：798-806.
|
| 14 |
Phillips B, Asgari E, Berry M, et al. British Transplantation Society guidelines on abdominal organ transplantation from deceased donors after circulatory death[J]. Transplant Rev (Orlando), 2024，38(1)：100801.
|
| 15 |
中国医师协会器官移植医师分会，中华医学会器官移植学分会，中华医学会外科学分会移植学组. 中国心脏死亡捐献器官评估与应用专家共识(2022版)[J/CD]. 中华移植杂志：电子版，2022，16(6)：321-328.
|
| 16 |
Sutherland DE, Goetz FC, Najarian JS. Report of twelve clinical cases of segmental pancreas transplantation at the University of Minnesota[J]. Transplant Proc, 1980，12(4 Suppl 2)：33-39.
|
| 17 |
Sutherland DE, Goetz FC, Najarian JS. Living-related donor segmental pancreatectomy for transplantation[J]. Transplant Proc, 1980，12(4 Suppl 2)：19-25.
|
| 18 |
Matsumoto S, Okitsu T, Iwanaga Y, et al. Insulin independence after living-donor distal pancreatectomy and islet allotransplantation[J]. Lancet, 2005，365(9471)：1642-1644.
|
| 19 |
Asano T, Kenmochi T. Preface to topic " Living donor pancreas transplantation" [J]. J Hepatobiliary Pancreat Sci, 2010，17(2)：91.
|
| 20 |
Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen[J]. N Engl J Med, 2000，343(4)：230-238.
|
| 21 |
Balamurugan AN, Naziruddin B, Lockridge A, et al. Islet product characteristics and factors related to successful human islet transplantation from the Collaborative Islet Transplant Registry (CITR) 1999-2010[J]. Am J Transplant, 2014，14(11)：2595-2606.
|
| 22 |
Hering BJ, Clarke WR, Bridges ND, et al. Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia[J]. Diabetes Care, 2016，39(7)：1230-1240.
|
| 23 |
Paget M, Murray H, Bailey CJ, et al. Human islet isolation: semi-automated and manual methods[J]. Diab Vasc Dis Res, 2007，4(1)：7-12.
|
| 24 |
Israni AK, Skeans MA, Gustafson SK, et al. OPTN/SRTR 2012 Annual Data Report: pancreas[J]. Am J Transplant, 2014，14 Suppl 1：45-68.
|
| 25 |
Israni AK, Zaun D, Rosendale JD, et al. OPTN/SRTR 2012 Annual Data Report: deceased organ donation[J]. Am J Transplant, 2014，14 Suppl 1：167-183.
|
| 26 |
Al-Adra DP, Gill RS, Imes S, et al. Single-donor islet transplantation and long-term insulin independence in select patients with type 1 diabetes mellitus[J]. Transplantation, 2014，98(9)：1007-1012.
|
| 27 |
Hering BJ, Kandaswamy R, Ansite JD, et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes[J]. JAMA, 2005，293(7)：830-835.
|
| 28 |
Bellin MD, Barton FB, Heitman A, et al. Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes[J]. Am J Transplant, 2012，12(6)：1576-1583.
|
| 29 |
Shapiro AM. Strategies toward single-donor islets of Langerhans transplantation[J]. Curr Opin Organ Transplant, 2011，16(6)：627-631.
|
| 30 |
Jablońska B, Mrowiec S. Total pancreatectomy with autologous islet cell transplantation-the current indications[J]. J Clin Med, 2021，10(12)：2723.
|
| 31 |
Wilson GC, Sutton JM, Smith MT, et al. Total pancreatectomy with islet cell autotransplantation as the initial treatment for minimal-change chronic pancreatitis[J]. HPB (Oxford), 2015，17(3)：232-238.
|
| 32 |
Chinnakotla S, Bellin MD, Schwarzenberg SJ, et al. Total pancreatectomy and islet autotransplantation in children for chronic pancreatitis: indication, surgical techniques, postoperative management, and long-term outcomes[J]. Ann Surg, 2014，260(1)：56-64.
|
| 33 |
Sutherland DE, Radosevich DM, Bellin MD, et al. Total pancreatectomy and islet autotransplantation for chronic pancreatitis[J]. J Am Coll Surg, 2012，214(4)：409-424.
|
| 34 |
Geyer MC, Coates PT, Khurana S, et al. First Report of Successful Total Pancreatectomy and Islet Autotransplant in Australia[J]. Pancreas, 2017，46(3)：e18-e20.
|
| 35 |
Savari O, Golab K, Wang LJ, et al. Preservation of beta cell function after pancreatic islet autotransplantation: University of Chicago experience[J]. Am Surg, 2015，81(4)：421-427.
|
| 36 |
Hu Q, Liu Z, Zhu H. Pig islets for islet xenotransplantation: current status and future perspectives[J]. Chin Med J (Engl), 2014，127(2)：370-377.
|
| 37 |
Matsumoto S, Shimoda M. Current situation of clinical islet transplantation from allogeneic toward xenogeneic[J]. J Diabetes, 2020，12(10)：733-741.
|
| 38 |
Hong SH, Kim HJ, Kang SJ, et al. Novel immunomodulatory approaches for porcine islet xenotransplantation[J]. Curr Diab Rep, 2021，21(1)：3.
|
| 39 |
Grimus S, Sarangova V, Welzel PB, et al. Immunoprotection strategies in beta-cell replacement therapy: a closer look at porcine islet xenotransplantation[J]. Adv Sci (Weinh), 2024，11(31)：e2401385.
|
| 40 |
Ekser B, Cooper DKC, Tector AJ. The need for xenotransplantation as a source of organs and cells for clinical transplantation[J]. Int J Surg, 2015，23(Pt B)：199-204.
|
| 41 |
Cheng M. Islet xeno/transplantation and the risk of contagion: local responses from Canada and Australia to an emerging global technoscience[J]. Life Sci Soc Policy, 2015，11：12.
|
| 42 |
Zhu HT, Yu L, Lyu Y, et al. Optimal pig donor selection in islet xenotransplantation: current status and future perspectives[J]. J Zhejiang Univ Sci B, 2014，15(8)：681-691.
|
| 43 |
Sakata N, Yoshimatsu G, Kawakami R, et al. The porcine islet-derived organoid showed the characteristics as pancreatic duct[J]. Sci Rep, 2024，14(1)：6401.
|
| 44 |
Nagaraju S, Bottino R, Wijkstrom M, et al. Islet xenotransplantation: what is the optimal age of the islet-source pig？[J]. Xenotransplantation, 2015，22(1)：7-19.
|
| 45 |
Zhu H, Yu L, He Y, et al. Microencapsulated pig islet xenotransplantation as an alternative treatment of diabetes[J]. Tissue Eng Part B Rev, 2015，21(5)：474-489.
|
| 46 |
Dufrane D, Goebbels RM, Fdilat I, et al. Impact of porcine islet size on cellular structure and engraftment after transplantation: adult versus young pigs[J]. Pancreas, 2005，30(2)：138-147.
|
| 47 |
Rajotte RV. Isolation and assessment of islet quality[J]. Xenotransplantation, 2008，15(2)：93-95.
|
| 48 |
Juang JH, Hsu BR, Kuo CH, et al. Characteristics and transplantation of the porcine neonatal pancreatic cell clusters isolated from 1- to 3-day-old versus 1-month-old pigs[J]. Transplant Proc, 2004，36(4)：1203-1205.
|
| 49 |
Luca G, Nastruzzi C, Calvitti M, et al. Accelerated functional maturation of isolated neonatal porcine cell clusters: in vitro and in vivo results in NOD mice[J]. Cell Transplant, 2005，14(5)：249-261.
|
| 50 |
Reardon S. New life for pig-to-human transplants[J]. Nature, 2015，527(7577)：152-154.
|
| 51 |
Ma X, Ye B, Gao F, et al. Tissue factor knockdown in porcine islets: an effective approach to suppressing the instant blood-mediated inflammatory reaction[J]. Cell Transplant, 2012，21(1)：61-71.
|
| 52 |
Hawthorne WJ, Salvaris EJ, Phillips P, et al. Control of IBMIR in neonatal porcine islet xenotransplantation in baboons[J]. Am J Transplant, 2014，14(6)：1300-1309.
|
| 53 |
Cowan PJ. The use of CRISPR/Cas associated technologies for cell transplant applications[J]. Curr Opin Organ Transplant, 2016，21(5)：461-466.
|
| 54 |
Otonkoski T. New tools for experimental diabetes research: cellular reprogramming and genome editing[J]. Ups J Med Sci, 2016，121(2)：146-150.
|
| 55 |
Czarnecka Z, Dadheech N, Razavy H, et al. The current status of allogenic islet cell transplantation[J]. Cells, 2023，12(20)：2423.
|
| 56 |
D′Amour KA, Bang AG, Eliazer S, et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells[J]. Nat Biotechnol, 2006，24(11)：1392-1401.
|
| 57 |
Kroon E, Martinson LA, Kadoya K, et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo[J]. Nat Biotechnol, 2008，26(4)：443-452.
|
| 58 |
Assady S, Maor G, Amit M, et al. Insulin production by human embryonic stem cells[J]. Diabetes, 2001，50(8)：1691-1697.
|
| 59 |
D′Amour KA, Agulnick AD, Eliazer S, et al. Efficient differentiation of human embryonic stem cells to definitive endoderm[J]. Nat Biotechnol, 2005，23(12)：1534-1541.
|
| 60 |
Wu J, Li T, Guo M, et al. Treating a type 2 diabetic patient with impaired pancreatic islet function by personalized endoderm stem cell-derived islet tissue[J]. Cell Discov, 2024，10(1)：45.
|
| 61 |
Ramzy A, Thompson DM, Ward-Hartstonge KA, et al. Implanted pluripotent stem-cell-derived pancreatic endoderm cells secrete glucose-responsive C-peptide in patients with type 1 diabetes[J]. Cell Stem Cell, 2021，28(12)：2047-2061.
|
| 62 |
Yang G, Fan X, Liu Y, et al. Immunomodulatory mechanisms and therapeutic potential of mesenchymal Stem Cells[J]. Stem Cell Rev Rep, 2023，19(5)：1214-1231.
|
| 63 |
Canning P, Alwan A, Khalil F, et al. Perspectives and challenges on the potential use of exosomes in bioartificial pancreas engineering[J]. Ann Biomed Eng, 2022，50(10)：1177-1186.
|
| 64 |
Song N, Scholtemeijer M, Shah K. Mesenchymal stem cell immunomodulation: mechanisms and therapeutic potential[J]. Trends Pharmacol Sci, 2020，41(9)：653-664.
|
| 65 |
Zhou Q, Brown J, Kanarek A, et al. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells[J]. Nature, 2008，455(7213)：627-632.
|
| 66 |
Banga A, Akinci E, Greder LV, et al. In vivo reprogramming of Sox9＋ cells in the liver to insulin-secreting ducts[J]. Proc Natl Acad Sci U S A, 2012，109(38)：15336-15341.
|
| 67 |
Hill CM, Banga A, Abrahante JE, et al. Establishing a large-animal model for in vivo reprogramming of bile duct cells into insulin-secreting cells to treat diabetes[J]. Hum Gene Ther Clin Dev, 2017，28(2)：87-95.
|
| 68 |
Klein D, Alvarez-Cubela S, Lanzoni G, et al. BMP-7 induces adult human pancreatic exocrine-to-endocrine conversion[J]. Diabetes, 2015，64(12)：4123-4134.
|
| 69 |
Wassmer CH, Lebreton F, Bellofatto K, et al. Bio-engineering of pre-vascularized islet organoids for the treatment of type 1 diabetes[J]. Transpl Int, 2021，35：10214.
|
| 70 |
Lebreton F, Hanna R, Wassmer CH, et al. Mechanisms of immunomodulation and cytoprotection conferred to pancreatic islet by human amniotic epithelial cells[J]. Stem Cell Rev Rep, 2022，18(1)：346-359.
|
| 71 |
Lebreton F, Lavallard V, Bellofatto K, et al. Insulin-producing organoids engineered from islet and amniotic epithelial cells to treat diabetes[J]. Nat Commun, 2019，10(1)：4491.
|
| 72 |
Mishra R, Roux BM, Posukonis M, et al. Effect of prevascularization on in vivo vascularization of poly(propylene fumarate)/fibrin scaffolds[J]. Biomaterials, 2016，77：255-266.
|
| 73 |
Später T, Frueh FS, Menger MD, et al. Potentials and limitations of Integra(R) flowable wound matrix seeded with adipose tissue-derived microvascular fragments[J]. Eur Cell Mater, 2017，33：268-278.
|
| 74 |
He F, Tao T, Liu H, et al. Controllable fabrication of composite core-shell capsules at a macroscale as organoid biocarriers[J]. ACS Appl Bio Mater, 2021，4(2)：1584-1596.
|
| 75 |
Ludwig B, Reichel A, Steffen A, et al. Transplantation of human islets without immunosuppression[J]. Proc Natl Acad Sci U S A, 2013，110(47)：19054-19058.
|
| 76 |
Stabler CL, Li Y, Stewart JM, et al. Engineering immunomodulatory biomaterials for type 1 diabetes[J]. Nat Rev Mater, 2019，4(6)：429-450.
|
| 77 |
Yan H, Melin M, Jiang K, et al. Immune-modulating mucin hydrogel microdroplets for the encapsulation of cell and microtissue[J]. Adv Funct Mater, 2021，31(42): 2105967.
|
| 78 |
Gattás-Asfura KM, Abuid NJ, Labrada I, et al. Promoting dendrimer self-assembly enhances covalent Layer-by-Layer encapsulation of pancreatic islets[J]. ACS Biomater Sci Eng, 2020，6(5)：2641-2651.
|
| 79 |
Gibly RF, Graham JG, Luo X, et al. Advancing islet transplantation: from engraftment to the immune response[J]. Diabetologia, 2011，54(10)：2494-2505.
|
| 80 |
Angaswamy N, Tiriveedhi V, Sarma NJ, et al. Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection[J]. Hum Immunol, 2013，74(11)：1478-1485.
|
| 81 |
Han Y, Liu D, Li L. PD-1/PD-L1 pathway: current researches in cancer[J]. Am J Cancer Res, 2020，10(3)：727-742.
|
| 82 |
Yoshihara E, O′Connor C, Gasser E, et al. Immune-evasive human islet-like organoids ameliorate diabetes[J]. Nature, 2020，586(7830)：606-611.
|
| 83 |
Gerace D, Zhou Q, Kenty JH, et al. Engineering human stem cell-derived islets to evade immune rejection and promote localized immune tolerance[J]. Cell Rep Med, 2023，4(1)：100879.
|
| 84 |
Bennet W, Groth CG, Larsson R, et al. Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes[J]. Ups J Med Sci, 2000，105(2)：125-133.
|
| 85 |
Bealer E, Crumley K, Clough D, et al. Extrahepatic transplantation of 3D cultured stem cell-derived islet organoids on microporous scaffolds[J]. Biomater Sci, 2023，11(10)：3645-3655.
|
| 86 |
Tillmar L, Welsh N. In vitro cultured rat islets express genes that both prevent and promote angiogenesis[J]. JOP, 2004，5(2)：81-91.
|
| 87 |
Chae HY, Lee BW, Oh SH, et al. Effective glycemic control achieved by transplanting non-viral cationic liposome-mediated VEGF-transfected islets in streptozotocin-induced diabetic mice[J]. Exp Mol Med, 2005；37(6)：513-523.
|
| 88 |
Hughes A, Mohanasundaram D, Kireta S, et al. Insulin-Like growth factor-II (IGF-II) prevents proinflammatory cytokine-induced apoptosis and significantly improves islet survival after transplantation[J]. Transplantation, 2013，95(5)：671-678.
|
| 89 |
Hughes A, Rojas-Canales D, Drogemuller C, et al. IGF2: an endocrine hormone to improve islet transplant survival[J]. J Endocrinol, 2014，221(2)：R41-R48.
|
| 90 |
Kim J, Shim IK, Hwang DG, et al. 3D cell printing of islet-laden pancreatic tissue-derived extracellular matrix bioink constructs for enhancing pancreatic functions[J]. J Mater Chem B, 2019，7(10)：1773-1781.
|